The LDN Research Trust approached us with a requirement for an app for a research study for the medication Low Dose Naltrexone (LDN).

We built a solution covering four different mobile platforms, a website and a research portal.  We also built the first global remote research study, covering 174 different conditions.  People from all over the world are able to now help get this medication approved for these conditions – and they are excited to be part of something that is going to make the difference for others in getting this medication approved.

myLDN will supply the statistical evidence required in regards to getting this medication approved for so many conditions.  Prior to our app, LDN Research Trust was reliant on research labs carrying out studies – and even a study would only be for one condition – certainly not 174!

At Bodymap Apps it is our philosophy to bring technology and research together – ultimately allowing for new medications and treatments being researched, from smaller labs and pharmaceutical companies.

Now more than ever before, we anticipate the use of research apps will setting the pace for new and exciting ways to help people gain back their quality of life by the use of medication and treatments.

 ‘LDN Research Trust are extremely pleased with our app myLDN. This app has allowed us to do the research and get the statistical evidence we need, as well as having patients from all over the world involved. Great job Bodymap Apps!’  Linda Elsegood, Chairman of the LDN Research Trust